Source: ThinkstockCelsion Corp. (NASDAQ: CLSN) was one of the more recent biotech implosions we have monitored. The company’s situation looked dire, and still does on a static basis. Now comes...
U.S. equity markets opened lower this morning and were never able to shake off the doldrums as stocks traded below the break-even line all day. There was little data out in either Asia or Europe, and...
October 29, 2013: U.S. markets opened higher Tuesday morning following the report on PPI which showed inflation remaining very low and indicating that the FOMC meeting which began today will...
U.S. equity markets opened lower this morning following a weekend of confusion over the proposed solution to the banking problem in Cyprus. It’s not that Cyprus claims a particularly large banking...
Investors in the biotech and biohealth space generally are taking on much more risk than in the likes of most Dow and S&P 500 stocks. That means they will demand more potential upside for that...
Celsion Corp. (NASDAQ: CLSN) watched its shares make an incredible gain on Tuesday after it received an even bigger upgrade from Oppenheimer. This came on the heels of new findings in its Liver...
Source: ThinkstockThe biotech sector is full of companies which will have great wins and horrible flops. The latter is the case today for Celsion (NASDAQ: CLSN). In fact, if you just look at the...